phase readout
saveNCT06588855: A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
RECRUITINGupdated 1d ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Moderately to Severely Active Ulcerative Colitis
view source ↗
comments(0)
5-min edit window · permanent after that